Axel is a Subjet Matter Expert ATMP at Propharma. Before joining in 2017 he had positions at the Swedish medical products agency for 16 years as a pharmaceutical assessor of biological products and also as a preclinical assessor. He has experience from clinical trials, scientific advice and marketing authorisations for biological products including recombinant products and advanced therapy products as well as oligonucleotide based medicines. Furthermore, as a long-time member of gene therapy working groups at EMA and EDQM he has long experience from writing EU guidelines and pharmacopoeia texts. At Propharma he is involved in drug related development projects as an expert in biological products in particular and non-clinical issues in general.